This week, a gene therapy for Leber hereditary optic neuropathy gains orphan drug designation, a novel eye drop for presbyopia is cleared for phase 2 trials and a common antidepressant shows early promise for amblyopia. Source: AAO
In this study, investigators examined the association between daily wearing of eyeglasses and susceptibility to COVID-19. Source: AAO
This was a retrospective, single-center case series of 7 patients diagnosed with acute posterior multifocal placoid pigment epitheliopathy. Source: AAO
This experimental study is the first to test the efficacy of slit-lamp breath shields in preventing droplet spray from a simulated sneeze. Source: AAO
The FDA has approved the first preservative-free, over-the-counter antihistamine drops for allergic conjunctivitis. Source: AAO
This retrospective study analyzed the frequency of systemic corticosteroid prescription before and after central serous chorioretinopathy (CSC) diagnosis. Source: AAO
This week, tocilizumab reduces the need for mechanical ventilation due to COVID-19, a gene therapy for dry AMD is fast-tracked by the FDA and Swiss scientists develop functional retinas in the lab. Source: AAO
This prospective longitudinal study characterized the morphologic and vascular changes in glaucomatous eyes. Source: AAO
This retrospective study evaluated the association between the use of 5α-reductase inhibitor (5-ARI) in men and macular abnormalities. Source: AAO
This case report describes corneal melt in a patient treated with topical interferon (INF) alpha 2b for conjunctival intraepithelial neoplasia (CIN) and carcinoma in situ of the cornea. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
